Commensal bacteria exacerbate intestinal inflammation but are not essential for the development of murine ileitis

被引:63
作者
Bamias, Giorgos [1 ]
Okazawa, Akira [1 ]
Rivera-Nieves, Jesus [1 ]
Arseneau, Kristen O. [1 ]
De La Rue, Sarah A. [1 ]
Pizarro, Theresa T. [1 ]
Cominelli, Fabio [1 ]
机构
[1] Univ Virginia, Hlth Sci Ctr, Digest Hlth Ctr Excellence, Charlottesville, VA 22908 USA
关键词
D O I
10.4049/jimmunol.178.3.1809
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The pathogenesis of Crohn's disease has been associated with a dysregulated response of the mucosal immune system against intraluminal Ags of bacterial origin. In this study, we have investigated the effects of germfree (GF) conditions in the SANW1/YitFc murine model of Crohn's disease-like ileitis. We show that the bacterial flora is not essential for ileitis induction, because GF SAMEP1/YitFc mice develop chronic ileitis. However, compared with disease in specific pathogen-free (SPF) mice, ileitis in GF mice is significantly attenuated, and is associated with delayed lymphocytic infiltration and defective mucosal expression of Th2 cytokines. In addition, we demonstrate that stimulation with purified fecal Ags from SPF, but not GF mice leads to the generation of IL-4-secreting effector lymphocytes. This result suggests that commensal bacteria drive Th2 responses characteristic of the chronic phase of SAMP1/YitFe ileitis. Finally, adoptive transfer of CD4-positive cells from GF, but not SPF mice induces severe colitis in SCID recipients. These effects were associated with a decreased frequency of CD4(+)CD25(+)Foxp3(+) T cells in the mesenteric lymph nodes of GF mice compared with SPF mice, as well as lower relative gene expression of Foxp3 in CD4(+)CD25(+) T cells in GF mice. It is therefore apparent that, in the. absence of live intraluminal bacteria, the regulatory component of the mucosal immune system is compromised. All together, our results indicate that in SAiMP1/YitFc mice, bacterial flora exacerbates intestinal inflammation, but is not essential for the generation of the chronic ileitis that is characteristic of these mice.
引用
收藏
页码:1809 / 1818
页数:10
相关论文
共 34 条
[1]   Sero-reactivity to microbial components in Crohn's disease is associated with disease severity and progression, but not NOD2/CARD15 genotype [J].
Arnott, IDR ;
Landers, CJ ;
Nimmo, EJ ;
Drummond, HE ;
Smith, BKR ;
Targan, SR ;
Satsangi, J .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (12) :2376-2384
[2]   Proinflammatory effects of TH2 cytokines in a murine model of chronic small intestinal inflammation [J].
Bamias, G ;
Martin, C ;
Mishina, M ;
Ross, WG ;
Rivera-Nieves, J ;
Marini, M ;
Cominelli, F .
GASTROENTEROLOGY, 2005, 128 (03) :654-666
[3]   Down-regulation of intestinal lymphocyte activation and Th1 cytokine production by antibiotic therapy in a murine model of Crohn's disease [J].
Bamias, G ;
Marini, M ;
Moskaluk, CA ;
Odashima, M ;
Ross, WG ;
Rivera-Nieves, J ;
Cominelli, F .
JOURNAL OF IMMUNOLOGY, 2002, 169 (09) :5308-5314
[4]   The immunological and genetic basis of inflammatory bowel disease [J].
Bouma, G ;
Strober, W .
NATURE REVIEWS IMMUNOLOGY, 2003, 3 (07) :521-533
[5]  
Brimnes J, 2001, EUR J IMMUNOL, V31, P23, DOI 10.1002/1521-4141(200101)31:1<23::AID-IMMU23>3.0.CO
[6]  
2-2
[7]   Bacterial-reactive T regulatory cells inhibit pathogenic immune responses to the enteric flora [J].
Cong, YZ ;
Weaver, CT ;
Lazenby, A ;
Elson, CO .
JOURNAL OF IMMUNOLOGY, 2002, 169 (11) :6112-6119
[8]   CD4+ T cells reactive to enteric bacterial antigens in spontaneously colitic C3H/HeJBir mice:: Increased T helper cell type 1 response and ability to transfer disease [J].
Cong, YZ ;
Brandwein, SL ;
McCabe, RP ;
Lazenby, A ;
Birkenmeier, EH ;
Sundberg, JP ;
Elson, CO .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (06) :855-864
[9]   T cell specificity and cross reactivity towards enterobacteria, Bacteroides, Bifidobacterium, and antigens from resident intestinal flora in humans [J].
Duchmann, R ;
May, E ;
Heike, M ;
Knolle, P ;
Neurath, M ;
zum Büschenfelde, KHM .
GUT, 1999, 44 (06) :812-818
[10]  
Duchmann R, 1995, CLIN EXP IMMUNOL, V102, P448